Brain Barrier Suppliers Near Libya

SynVivo is a cell-based microfluidic organ-on-chip platform that provides a biologically realistic microenvironment for the real-time study of cellular behavior, drug delivery, and drug discovery. This proprietary technology links the high-tech ...

Founded in 2005, by Alexandre TOKAY, CEO, and Dr. Michel KHRESTCHATISKY, Scientific Advisor, VECT-HORUS is a spin-off of the NICN UMR7259 (CNRS and Aix-Marseille University) now Institute for NeuroPhysiopathology (INP) directed by Dr. Michel ...

Novel therapeutics are lacking for Brain Cancer. Only four of the 217 FDA-approved oncology medicines are indicated for life-threatening brain cancers. The most recent approval was in 2009 and did not extend life expectancy. Patients deserve better ...

Lauren Sciences is a privately-held New York biotechnology company focused on developing its V-Smart platform to create a robust pipeline of V-Smart therapeutics consisting of central nervous system (CNS)-active drugs that normally do not cross the ...

Award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The company is targeting anxiety, depression, ...

Kurve Therapeutics drug delivery technology is designed to target the most difficult part of the treatment process - getting medication through the blood-brain barrier and into the brain. Kurve Therapeutics has 18 peer-reviewed publications of ...

Tempo Bioscience, Inc (Tempo) develops human stem cells (human iPSC technology) based cell models and biosensor enabling technologies for preclinical drug discovery & development, biobanking, in vitro diagnostics, and biomarker development. Our ...

BioArctic is a Swedish research intensive biopharma company aimed at developing new treatments that address the causes of disorders that affect the Central Nervous System. These types of treatments are commonly referred to as disease modifiers. They ...

Lys Therapeutics, first-in-class biotherapies against neurological diseases. Lys Therapeutics is a French biotech company developing innovative drugs to treat patients suffering from neurovascular or neurodegenerative disorders, including stroke and ...

At EnClear Therapies, our goal is to improve and extend the lives of patients with a wide variety of CNS disease through precision dosing. We are building an Integrated Neurotechnology Business using our CSF Health Platform to create a pipeline of ...

Neuroscientific Biopharmaceuticals is an Australian public company (ASX:NSB) developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical need. Our vision ...

Jubilant Radiopharma is a global leader in the development, manufacturing, and commercialization of radiopharmaceuticals used for the diagnosis and treatment of disease. We serve our customers – and through them patients – with high-quality and ...

Nexelis is your partner for assay and biomarker development, advanced bioanalytical and laboratory testing, and translational immunology. As the leading specialty laboratory, we have unrivaled expertise in immunology, specifically in the areas of ...

As a global life sciences company, Emergent offers specialized products to healthcare providers and governments to address medical needs and emerging health threats. Protecting and Enhancing 50 million lives by 2025 focuses our energy to improve the ...

RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of ...

Biotron Limited (Biotron) is a clinical stage publicly listed Australian Biotechnology Company based in Sydney, Australia. The company is developing and commercialising a novel small molecule approach that has the potential to treat a number of ...

SonALAsense’s ALA sonodynamic therapy (SDT) is well differentiated from the use of other forms of therapy which have been used for GBM or rGBM. Our use of a MRI-guided focused ultrasound device with ALA is a true drug-device combination, where both ...

We are a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. Our mission is to improve patient outcomes and save lives. To achieve our mission, we seek to capitalize on ...

Neurovision Medical Products develops intraoperative neuromonitoring technology and products that assist in preserving motor nerves. Founded in 1973, we continue to redefine nerve monitoring technology through the integration of surgical principles ...

Rockland Immunochemicals, Inc. offers a robust catalog of antibodies to suit any project. No matter the context—basic research to disease therapy, phosphorylated to methylated, and beyond—Rockland embraces the challenge to design, produce, validate, ...